FlowPants
Commercial- Indications
- Benign prostatic hyperplasia, Urinary hesitancy, Nocturia
Company intelligence / Profile preview
X-Therma has developed a proprietary peptoid-based biopreservation platform enabling DMSO-free, non-toxic cryopreservation of cells, tissues, and organs at ultra-low temperatures. Its XT-Thrive® product is cGMP-ready for clinical/commercial use in cell/gene therapy manufacturing. The XT-ViVo® & TimeSeal® system received FDA Breakthrough Device Designation after demonstrating successful multi-day subzero organ preservation—including world-first 48-hour transatlantic pig kidney transports—poised to transform organ transplantation logistics and outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ThermaRx.